Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -6.76%.However, over the last six months, we can see a stronger performance of -4.34%. Over the last 30 days, the price of ROIV has fallen by 21.48%. And in the last five days, it has fallen by -4.75%.
Roivant Sciences Ltd experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $13.06 on 09/09/24, while the lowest price for the same period was registered at $8.73 on 04/07/25.
52-week price history of ROIV Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Roivant Sciences Ltd’s current trading price is -15.51% away from its 52-week high, while its distance from the 52-week low is 26.35%. The stock’s price range during this period has varied between$8.73 and $13.06. The Roivant Sciences Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 5.8 million for the day, a figure considerably lower than their average daily volume of 6.63 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Roivant Sciences Ltd (ROIV) has experienced a quarterly rise of 1.47% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.87B and boasts a workforce of 908 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.85, with a change in price of -1.08. Similarly, Roivant Sciences Ltd recorded 5,848,776 in trading volume during the last 100 days, posting a change of -8.92%.
ROIV’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ROIV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
ROIV Stock Stochastic Average
Roivant Sciences Ltd’s raw stochastic average for the past 50 days is presently 75.66%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 70.75%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 74.98% and 81.29%, respectively.
